Nivalis Therapeutics ALPN 深 沪

Arcutis Expands Board of Directors with Appointment of Chris Peetz

Arcutis Biotherapeutics appoints Chris Peetz to its Board of Directors. Peetz, a biopharmaceutical executive with extensive experience, will help the company expand its ZORYVE franchise and pipeline. ZORYVE, a topical PDE4 inhibitor, is the leading branded therapy for inflammatory skin diseases. Peetz's leadership is expected to drive Arcutis' growth and innovation in immuno-dermatology.

07-16 13:00

Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors

04-06 12:00

Wedbush：重申Alpine Immune Sciences(ALPN.US)评级，由中性调整至中性评级, 目标价65.00美元。

Wedbush：重申Alpine Immune Sciences(ALPN.US)评级，由中性调整至中性评级, 目标价65.00美元。

2024-05-16 20:40

Alpine Immune Sciences Q1 EPS $(0.28) Beats $(0.41) Estimate, Sales $7.03M Beat $3.52M Estimate

Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.41) by 31.71 percent. This is unchanged from the same period last year. The company

2024-05-10 04:25

Alpine Immune Sciences Communicates Key Updates Regularly

The latest announcement is out from Alpine Immune Sciences Inc (ALPN). Alpine I...

2024-05-10 04:24

美股牛股 | RLYB隔夜涨82.8%；MGRM宣布加入英伟达创始计划，隔夜大涨79.3%

RLYB隔夜涨82.8%，与强生签署开发协议；MGRM宣布加入英伟达创始计划，隔夜大涨79.3%>>

2024-04-12 19:32

华盛早报 | 科技股狂欢！苹果一夜飙涨千亿美元；金价再度刷新历史新高

科技股狂欢！苹果一夜飙涨1100亿美元；FOMC“二把手”称短期无需下调利率；黄金再破历史新高！华尔街大佬喊话金价将突破3000美元>>

2024-04-12 08:28